Protease - Activated Receptor - 4, PAR - 4 Agonist, amide, human incorporates the minimal activation motif tailored to human PAR-4. Amidation at the C-terminus enhances stability and receptor engagement in biochemical assays. Sequence architecture supports studies on protease cleavage specificity. Researchers use it to dissect early signaling events and conformational changes in PAR-4 pathways.
CAT No: T05037
Synonyms/Alias:Protease - Activated Receptor - 4, PAR - 4 Agonist, amide, human;
1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.